ReP USP - Resultado da busca

Artigo de periodico
Liver elastography can predict degree of advanced fibrosis for autoimmune hepatitis in biochemical remission (2023)
Paranaguá-Vezozzo, Denise Cerqueira; Terrabuio, Débora Raquel Benedita; Pereira, Gleicy Luz Reinoso; Moutinho, Renata; Ono, Suzane Kioko; Salas, Veronica Walwyn; França, Joao Italo Dias; Cançado, Eduardo Luiz Rachid; Carrilho, Flair José; Alves, Venancio Avancini Ferreira
Source: Jgh open. Unidade: FM
Subjects: ULTRASSONOGRAFIA, HEPATITE AUTOIMUNE, CIRROSE HEPÁTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PARANAGUÁ-VEZOZZO, Denise Cerqueira et al. Liver elastography can predict degree of advanced fibrosis for autoimmune hepatitis in biochemical remission. Jgh open, v. 7, n. 4, p. 272-277, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/53912. Acesso em: 30 jun. 2024.
APA
Paranaguá-Vezozzo, D. C., Terrabuio, D. R. B., Pereira, G. L. R., Moutinho, R., Ono, S. K., Salas, V. W., et al. (2023). Liver elastography can predict degree of advanced fibrosis for autoimmune hepatitis in biochemical remission. Jgh open, 7( 4), 272-277. doi:10.1002/jgh3.12865
NLM
Paranaguá-Vezozzo DC, Terrabuio DRB, Pereira GLR, Moutinho R, Ono SK, Salas VW, França JID, Cançado ELR, Carrilho FJ, Alves VAF. Liver elastography can predict degree of advanced fibrosis for autoimmune hepatitis in biochemical remission [Internet]. Jgh open. 2023 ; 7( 4): 272-277.[citado 2024 jun. 30 ] Available from: https://observatorio.fm.usp.br/handle/OPI/53912
Vancouver
Paranaguá-Vezozzo DC, Terrabuio DRB, Pereira GLR, Moutinho R, Ono SK, Salas VW, França JID, Cançado ELR, Carrilho FJ, Alves VAF. Liver elastography can predict degree of advanced fibrosis for autoimmune hepatitis in biochemical remission [Internet]. Jgh open. 2023 ; 7( 4): 272-277.[citado 2024 jun. 30 ] Available from: https://observatorio.fm.usp.br/handle/OPI/53912
Artigo de periodico
Adjuvant vaccination with allogenic dendritic cells significantly prolongs overall survival in high-grade gliomas: results of a phase II trial (2023)
Lepski, Guilherme ; Bergami-Santos, Patricia C. ; Pinho, Mariana P. ; Chauca-Torres, Nadia E. ; Evangelista, Gabriela C. M. ; Teixeira, Sarah F. ; Flatow, Elizabeth ; Oliveira, Jaqueline V. de ; Fogolin, Carla ; Peres, Nataly ; Arévalo, Analía ; Alves, Venâncio A. F. ; Barbuto, José Alexandre Marzagão
Source: Cancers. Unidades: FM, ICB
Subjects: IMUNOLOGIA, NEOPLASIAS CEREBRAIS, GLIOMA, IMUNOTERAPIA, ADJUVANTES IMUNOLÓGICOS, CÉLULAS DENDRÍTICAS, ASTROCITOMA, CÉLULAS CULTIVADAS DE TUMOR, VACINAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LEPSKI, Guilherme et al. Adjuvant vaccination with allogenic dendritic cells significantly prolongs overall survival in high-grade gliomas: results of a phase II trial. Cancers, v. 15, n. 4, p. 1-12, 2023Tradução . . Disponível em: https://doi.org/10.3390/cancers15041239. Acesso em: 30 jun. 2024.
APA
Lepski, G., Bergami-Santos, P. C., Pinho, M. P., Chauca-Torres, N. E., Evangelista, G. C. M., Teixeira, S. F., et al. (2023). Adjuvant vaccination with allogenic dendritic cells significantly prolongs overall survival in high-grade gliomas: results of a phase II trial. Cancers, 15( 4), 1-12. doi:10.3390/cancers15041239
NLM
Lepski G, Bergami-Santos PC, Pinho MP, Chauca-Torres NE, Evangelista GCM, Teixeira SF, Flatow E, Oliveira JV de, Fogolin C, Peres N, Arévalo A, Alves VAF, Barbuto JAM. Adjuvant vaccination with allogenic dendritic cells significantly prolongs overall survival in high-grade gliomas: results of a phase II trial [Internet]. Cancers. 2023 ; 15( 4): 1-12.[citado 2024 jun. 30 ] Available from: https://doi.org/10.3390/cancers15041239
Vancouver
Lepski G, Bergami-Santos PC, Pinho MP, Chauca-Torres NE, Evangelista GCM, Teixeira SF, Flatow E, Oliveira JV de, Fogolin C, Peres N, Arévalo A, Alves VAF, Barbuto JAM. Adjuvant vaccination with allogenic dendritic cells significantly prolongs overall survival in high-grade gliomas: results of a phase II trial [Internet]. Cancers. 2023 ; 15( 4): 1-12.[citado 2024 jun. 30 ] Available from: https://doi.org/10.3390/cancers15041239
Artigo de periodico
Early variation of inflammatory indexes refines prognostic prediction in patients with hepatocellular carcinoma under systemic treatment (2023)
Fonseca, Leonardo Gomes da ; Uratani, Lucas Fernando; Soares, Gabriella Fernandes; Amaral, Paulo Siqueira do; Alencar, Regiane Saraiva de Souza Melo; Chagas, Aline Lopes; Alves, Venancio Avancini Ferreira ; Carrilho, Flair José
Source: Molecular and clinical oncology. Unidade: FM
Subjects: NEOPLASIAS HEPÁTICAS, CARCINOMA HEPATOCELULAR, PROGNÓSTICO, INFLAMAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FONSECA, Leonardo Gomes da et al. Early variation of inflammatory indexes refines prognostic prediction in patients with hepatocellular carcinoma under systemic treatment. Molecular and clinical oncology, v. 18, n. 4, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/53100. Acesso em: 30 jun. 2024.
APA
Fonseca, L. G. da, Uratani, L. F., Soares, G. F., Amaral, P. S. do, Alencar, R. S. de S. M., Chagas, A. L., et al. (2023). Early variation of inflammatory indexes refines prognostic prediction in patients with hepatocellular carcinoma under systemic treatment. Molecular and clinical oncology, 18( 4). doi:10.3892/mco.2023.2625
NLM
Fonseca LG da, Uratani LF, Soares GF, Amaral PS do, Alencar RS de SM, Chagas AL, Alves VAF, Carrilho FJ. Early variation of inflammatory indexes refines prognostic prediction in patients with hepatocellular carcinoma under systemic treatment [Internet]. Molecular and clinical oncology. 2023 ; 18( 4):[citado 2024 jun. 30 ] Available from: https://observatorio.fm.usp.br/handle/OPI/53100
Vancouver
Fonseca LG da, Uratani LF, Soares GF, Amaral PS do, Alencar RS de SM, Chagas AL, Alves VAF, Carrilho FJ. Early variation of inflammatory indexes refines prognostic prediction in patients with hepatocellular carcinoma under systemic treatment [Internet]. Molecular and clinical oncology. 2023 ; 18( 4):[citado 2024 jun. 30 ] Available from: https://observatorio.fm.usp.br/handle/OPI/53100
Artigo de periodico
Oncocytic Meningioma: Case Report of a Rare Meningioma Variant (2023)
Casal, Yuri Reis; Teixeira, Livia Porto; Bandeira, Gabriela Alencar; Porceban, Matheus Moreli; Paiva, Wellingson Silva; Godoy, Luis Filipe de Souza; http://orcid.org/0000-0003-4872-1731; Lucato, Leandro Tavares; Alves, Venancio Avancini Ferreira; Frassetto, Fernando Pereira
Source: Brazilian neurosurgery-arquivos brasileiros de neurocirurgia. Unidade: FM
Subjects: MENINGIOMA, DIAGNÓSTICO POR IMAGEM, NEOPLASIAS MENÍNGEAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CASAL, Yuri Reis et al. Oncocytic Meningioma: Case Report of a Rare Meningioma Variant. Brazilian neurosurgery-arquivos brasileiros de neurocirurgia, v. 42, n. 1, p. E79-E84, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/54063. Acesso em: 30 jun. 2024.
APA
Casal, Y. R., Teixeira, L. P., Bandeira, G. A., Porceban, M. M., Paiva, W. S., Godoy, L. F. de S., et al. (2023). Oncocytic Meningioma: Case Report of a Rare Meningioma Variant. Brazilian neurosurgery-arquivos brasileiros de neurocirurgia, 42( 1), E79-E84. doi:10.1055/s-0042-1743556
NLM
Casal YR, Teixeira LP, Bandeira GA, Porceban MM, Paiva WS, Godoy LF de S, http://orcid.org/0000-0003-4872-1731, Lucato LT, Alves VAF, Frassetto FP. Oncocytic Meningioma: Case Report of a Rare Meningioma Variant [Internet]. Brazilian neurosurgery-arquivos brasileiros de neurocirurgia. 2023 ; 42( 1): E79-E84.[citado 2024 jun. 30 ] Available from: https://observatorio.fm.usp.br/handle/OPI/54063
Vancouver
Casal YR, Teixeira LP, Bandeira GA, Porceban MM, Paiva WS, Godoy LF de S, http://orcid.org/0000-0003-4872-1731, Lucato LT, Alves VAF, Frassetto FP. Oncocytic Meningioma: Case Report of a Rare Meningioma Variant [Internet]. Brazilian neurosurgery-arquivos brasileiros de neurocirurgia. 2023 ; 42( 1): E79-E84.[citado 2024 jun. 30 ] Available from: https://observatorio.fm.usp.br/handle/OPI/54063
Artigo de periodico
P53 and VEGF are promising biomarkers for sorafenib efficacy in an experimental model of NASH‑related HCC (2023)
Reis, João Pedro Nassar; Umeta, Pedro Fukui; Stefano, José Tadeu ; Longatto Filho, Adhemar ; Carrilho, Flair José ; Alves, Venancio Avancini Ferreira ; Cogliati, Bruno ; Oliveira, Cláudia Pinto Marques Souza de
Source: Journal of Molecular Histology. Unidades: FM, FMVZ
Subjects: CARCINOMA HEPATOCELULAR, HEPATITE, INIBIDORES DE ENZIMAS, BIOMARCADORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
REIS, João Pedro Nassar et al. P53 and VEGF are promising biomarkers for sorafenib efficacy in an experimental model of NASH‑related HCC. Journal of Molecular Histology, v. 54, p. 473-488, 2023Tradução . . Disponível em: https://doi.org/10.1007/s10735-023-10142-9. Acesso em: 30 jun. 2024.
APA
Reis, J. P. N., Umeta, P. F., Stefano, J. T., Longatto Filho, A., Carrilho, F. J., Alves, V. A. F., et al. (2023). P53 and VEGF are promising biomarkers for sorafenib efficacy in an experimental model of NASH‑related HCC. Journal of Molecular Histology, 54, 473-488. doi:10.1007/s10735-023-10142-9
NLM
Reis JPN, Umeta PF, Stefano JT, Longatto Filho A, Carrilho FJ, Alves VAF, Cogliati B, Oliveira CPMS de. P53 and VEGF are promising biomarkers for sorafenib efficacy in an experimental model of NASH‑related HCC [Internet]. Journal of Molecular Histology. 2023 ; 54 473-488.[citado 2024 jun. 30 ] Available from: https://doi.org/10.1007/s10735-023-10142-9
Vancouver
Reis JPN, Umeta PF, Stefano JT, Longatto Filho A, Carrilho FJ, Alves VAF, Cogliati B, Oliveira CPMS de. P53 and VEGF are promising biomarkers for sorafenib efficacy in an experimental model of NASH‑related HCC [Internet]. Journal of Molecular Histology. 2023 ; 54 473-488.[citado 2024 jun. 30 ] Available from: https://doi.org/10.1007/s10735-023-10142-9
Artigo de periodico
Profile of MicroRNAs associated with death due to disease progression in metastatic papillary Thyroid Carcinoma patients (2023)
Leite, Ana Kober Nogueira ; Saito, Kelly Cristina ; Theodoro, Thérèse Rachell ; Pasini, Fátima Solange ; Camilo, Luana Perrone ; Rossetti, Carlos Augusto ; Cavalheiro, Beatriz Godoi ; Alves, Venancio Avancini Ferreira ; Kowalski, Luiz Paulo ; Kimura, Edna Teruko ; Matos, Leandro Luongo
Source: Cancers. Unidades: ICB, FM
Subjects: BIOLOGIA CELULAR, MICRORNAS, NEOPLASIAS DA TIREOIDE, CARCINOMA PAPILAR, METÁSTASE NEOPLÁSICA, MUTAÇÃO GENÉTICA, REAÇÃO EM CADEIA POR POLIMERASE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LEITE, Ana Kober Nogueira et al. Profile of MicroRNAs associated with death due to disease progression in metastatic papillary Thyroid Carcinoma patients. Cancers, v. 15, n. 3, p. 1-12, 2023Tradução . . Disponível em: https://doi.org/10.3390/cancers15030869. Acesso em: 30 jun. 2024.
APA
Leite, A. K. N., Saito, K. C., Theodoro, T. R., Pasini, F. S., Camilo, L. P., Rossetti, C. A., et al. (2023). Profile of MicroRNAs associated with death due to disease progression in metastatic papillary Thyroid Carcinoma patients. Cancers, 15( 3), 1-12. doi:10.3390/cancers15030869
NLM
Leite AKN, Saito KC, Theodoro TR, Pasini FS, Camilo LP, Rossetti CA, Cavalheiro BG, Alves VAF, Kowalski LP, Kimura ET, Matos LL. Profile of MicroRNAs associated with death due to disease progression in metastatic papillary Thyroid Carcinoma patients [Internet]. Cancers. 2023 ; 15( 3): 1-12.[citado 2024 jun. 30 ] Available from: https://doi.org/10.3390/cancers15030869
Vancouver
Leite AKN, Saito KC, Theodoro TR, Pasini FS, Camilo LP, Rossetti CA, Cavalheiro BG, Alves VAF, Kowalski LP, Kimura ET, Matos LL. Profile of MicroRNAs associated with death due to disease progression in metastatic papillary Thyroid Carcinoma patients [Internet]. Cancers. 2023 ; 15( 3): 1-12.[citado 2024 jun. 30 ] Available from: https://doi.org/10.3390/cancers15030869
Artigo de periodico
Hepatocellular carcinoma (HCC) in patients with Non-Alcoholic Fatty Liver Disease (NAFLD): screening, treatment and survival analysis in a Brazilian series (2022)
Alencar, Regiane Saraiva de Souza Melo; Oliveira, Claudia P. ; Chagas, Aline Lopes; Fonseca, Leonardo Gomes da ; Maccali, Claudia; Saud, Lisa Rodrigues da Cunha; Xerfan, Mariana Pinheiro ; Stefano, José Tadeu ; Herman, Paulo ; D'albuquerque, Luiz Augusto Carneiro
Source: Clinics. Unidade: FM
Subjects: CIRROSE HEPÁTICA, NEOPLASIAS HEPÁTICAS, CARCINOMA HEPATOCELULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ALENCAR, Regiane Saraiva de Souza Melo et al. Hepatocellular carcinoma (HCC) in patients with Non-Alcoholic Fatty Liver Disease (NAFLD): screening, treatment and survival analysis in a Brazilian series. Clinics, v. 77, 2022Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/50508. Acesso em: 30 jun. 2024.
APA
Alencar, R. S. de S. M., Oliveira, C. P., Chagas, A. L., Fonseca, L. G. da, Maccali, C., Saud, L. R. da C., et al. (2022). Hepatocellular carcinoma (HCC) in patients with Non-Alcoholic Fatty Liver Disease (NAFLD): screening, treatment and survival analysis in a Brazilian series. Clinics, 77. doi:10.1016/j.clinsp.2022.100097
NLM
Alencar RS de SM, Oliveira CP, Chagas AL, Fonseca LG da, Maccali C, Saud LR da C, Xerfan MP, Stefano JT, Herman P, D'albuquerque LAC. Hepatocellular carcinoma (HCC) in patients with Non-Alcoholic Fatty Liver Disease (NAFLD): screening, treatment and survival analysis in a Brazilian series [Internet]. Clinics. 2022 ; 77[citado 2024 jun. 30 ] Available from: https://observatorio.fm.usp.br/handle/OPI/50508
Vancouver
Alencar RS de SM, Oliveira CP, Chagas AL, Fonseca LG da, Maccali C, Saud LR da C, Xerfan MP, Stefano JT, Herman P, D'albuquerque LAC. Hepatocellular carcinoma (HCC) in patients with Non-Alcoholic Fatty Liver Disease (NAFLD): screening, treatment and survival analysis in a Brazilian series [Internet]. Clinics. 2022 ; 77[citado 2024 jun. 30 ] Available from: https://observatorio.fm.usp.br/handle/OPI/50508
Artigo de periodico
Brazilian society of hepatology updated recommendations for diagnosis and treatment of hepatocellular carcinoma (2020)
Chagas, Aline Lopes; Carrilho, Flair José ; Vezozzo, Denise Cerqueira Paranagua; Horvat, Natally de Souza Maciel Rocha ; Rocha, Manoel de Souza ; Alves, Venancio Avancini Ferreira ; Monsignore, Lucas Moretti ; Coelho, Fabricio Ferreira ; D Albuquerque, Luiz Augusto Carneiro ; Braghiroli, Maria Ignez Freitas Melro; Hoff, Paulo Marcelo Gehm
Source: Arquivos de Gastroenterologia. Unidades: FM, FMRP
Subjects: EPIDEMIOLOGIA, CARCINOMA, PATOLOGIA, NEOPLASIAS, ESTUDO DE CASO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CHAGAS, Aline Lopes et al. Brazilian society of hepatology updated recommendations for diagnosis and treatment of hepatocellular carcinoma. Arquivos de Gastroenterologia, v. 57, p. 1-20, 2020Tradução . . Disponível em: https://doi.org/10.1590/S0004-2803.202000000-20. Acesso em: 30 jun. 2024.
APA
Chagas, A. L., Carrilho, F. J., Vezozzo, D. C. P., Horvat, N. de S. M. R., Rocha, M. de S., Alves, V. A. F., et al. (2020). Brazilian society of hepatology updated recommendations for diagnosis and treatment of hepatocellular carcinoma. Arquivos de Gastroenterologia, 57, 1-20. doi:10.1590/S0004-2803.202000000-20
NLM
Chagas AL, Carrilho FJ, Vezozzo DCP, Horvat N de SMR, Rocha M de S, Alves VAF, Monsignore LM, Coelho FF, D Albuquerque LAC, Braghiroli MIFM, Hoff PMG. Brazilian society of hepatology updated recommendations for diagnosis and treatment of hepatocellular carcinoma [Internet]. Arquivos de Gastroenterologia. 2020 ; 57 1-20.[citado 2024 jun. 30 ] Available from: https://doi.org/10.1590/S0004-2803.202000000-20
Vancouver
Chagas AL, Carrilho FJ, Vezozzo DCP, Horvat N de SMR, Rocha M de S, Alves VAF, Monsignore LM, Coelho FF, D Albuquerque LAC, Braghiroli MIFM, Hoff PMG. Brazilian society of hepatology updated recommendations for diagnosis and treatment of hepatocellular carcinoma [Internet]. Arquivos de Gastroenterologia. 2020 ; 57 1-20.[citado 2024 jun. 30 ] Available from: https://doi.org/10.1590/S0004-2803.202000000-20
Artigo de periodico
Immunohistochemical assessment of the expression of biliary transportation proteins MRP2 and MRP3 in hepatocellular carcinoma and in cholangiocarcinoma (2019)
Cirqueira, Cinthya Santos; Felipe-Silva, Aloísio Sousa; Wakamatsu, Alda; Marins, Lidiane Vieira; Rocha, Eziel Cavalcanti; Mello, Evandro Sobroza de; Alves, Venâncio Avancini Ferreira
Source: Pathology and Oncology Research. Unidades: HU, FM
Subjects: CARCINOMA HEPATOCELULAR, IMUNOHISTOQUÍMICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CIRQUEIRA, Cinthya Santos et al. Immunohistochemical assessment of the expression of biliary transportation proteins MRP2 and MRP3 in hepatocellular carcinoma and in cholangiocarcinoma. Pathology and Oncology Research, v. 25, n. 4, p. 1363-1371, 2019Tradução . . Disponível em: https://doi.org/10.1007/s12253-018-0386-8. Acesso em: 30 jun. 2024.
APA
Cirqueira, C. S., Felipe-Silva, A. S., Wakamatsu, A., Marins, L. V., Rocha, E. C., Mello, E. S. de, & Alves, V. A. F. (2019). Immunohistochemical assessment of the expression of biliary transportation proteins MRP2 and MRP3 in hepatocellular carcinoma and in cholangiocarcinoma. Pathology and Oncology Research, 25( 4), 1363-1371. doi:10.1007/s12253-018-0386-8
NLM
Cirqueira CS, Felipe-Silva AS, Wakamatsu A, Marins LV, Rocha EC, Mello ES de, Alves VAF. Immunohistochemical assessment of the expression of biliary transportation proteins MRP2 and MRP3 in hepatocellular carcinoma and in cholangiocarcinoma [Internet]. Pathology and Oncology Research. 2019 ; 25( 4): 1363-1371.[citado 2024 jun. 30 ] Available from: https://doi.org/10.1007/s12253-018-0386-8
Vancouver
Cirqueira CS, Felipe-Silva AS, Wakamatsu A, Marins LV, Rocha EC, Mello ES de, Alves VAF. Immunohistochemical assessment of the expression of biliary transportation proteins MRP2 and MRP3 in hepatocellular carcinoma and in cholangiocarcinoma [Internet]. Pathology and Oncology Research. 2019 ; 25( 4): 1363-1371.[citado 2024 jun. 30 ] Available from: https://doi.org/10.1007/s12253-018-0386-8
Artigo de periodico
External validation of the AJCC Cancer Staging Manual, 8th edition, in an independent cohort of oral cancer patients (2017)
Matos, Leandro Luongo; Dedivitis, Rogerio Aparecido; Kulcsar, Marco Aurélio Vamondes; Mello, Evandro Sobroza de; Alves, Venâncio Avancini F.; Cernea, Claudio Roberto
Source: Oral Oncology. Unidade: FM
Subjects: RECIDIVA, BOCA, METÁSTASE NEOPLÁSICA, NEOPLASIAS DE CABEÇA E PESCOÇO, SOBREVIVÊNCIA LIVRE DE DOENÇA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MATOS, Leandro Luongo et al. External validation of the AJCC Cancer Staging Manual, 8th edition, in an independent cohort of oral cancer patients. Oral Oncology, v. 71, p. 47-53, 2017Tradução . . Disponível em: https://doi.org/10.1016/j.oraloncology.2017.05.020. Acesso em: 30 jun. 2024.
APA
Matos, L. L., Dedivitis, R. A., Kulcsar, M. A. V., Mello, E. S. de, Alves, V. A. F., & Cernea, C. R. (2017). External validation of the AJCC Cancer Staging Manual, 8th edition, in an independent cohort of oral cancer patients. Oral Oncology, 71, 47-53. doi:10.1016/j.oraloncology.2017.05.020
NLM
Matos LL, Dedivitis RA, Kulcsar MAV, Mello ES de, Alves VAF, Cernea CR. External validation of the AJCC Cancer Staging Manual, 8th edition, in an independent cohort of oral cancer patients [Internet]. Oral Oncology. 2017 ; 71 47-53.[citado 2024 jun. 30 ] Available from: https://doi.org/10.1016/j.oraloncology.2017.05.020
Vancouver
Matos LL, Dedivitis RA, Kulcsar MAV, Mello ES de, Alves VAF, Cernea CR. External validation of the AJCC Cancer Staging Manual, 8th edition, in an independent cohort of oral cancer patients [Internet]. Oral Oncology. 2017 ; 71 47-53.[citado 2024 jun. 30 ] Available from: https://doi.org/10.1016/j.oraloncology.2017.05.020
Artigo de periodico
Omega-3 polyunsaturated fatty acids in treating non-alcoholic steatohepatitis: a randomized, double-blind, placebo-controlled trial (2016)
Nogueira, Monize Aydar; Oliveira, Cláudia Pinto Marques Souza de; Alves, Venâncio Avancini Ferreira; Stefano, José Tadeu; Rodrigues, Lívia Samara dos Reis; Torrinhas, Raquel Suzana; Cogliati, Bruno; Barbeiro, Hermes Vieira; Carrilho, Flair José; Waitzberg, Dan Linetzky
Source: Clinical Nutrition. Unidades: FM, FMVZ
Subjects: HEPATITE, ÁCIDOS GRAXOS OMEGA 3, METABOLISMO DE GORDURA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NOGUEIRA, Monize Aydar et al. Omega-3 polyunsaturated fatty acids in treating non-alcoholic steatohepatitis: a randomized, double-blind, placebo-controlled trial. Clinical Nutrition, v. 35, n. 3, p. 578-586, 2016Tradução . . Disponível em: https://doi.org/10.1016/j.clnu.2015.05.001. Acesso em: 30 jun. 2024.
APA
Nogueira, M. A., Oliveira, C. P. M. S. de, Alves, V. A. F., Stefano, J. T., Rodrigues, L. S. dos R., Torrinhas, R. S., et al. (2016). Omega-3 polyunsaturated fatty acids in treating non-alcoholic steatohepatitis: a randomized, double-blind, placebo-controlled trial. Clinical Nutrition, 35( 3), 578-586. doi:10.1016/j.clnu.2015.05.001
NLM
Nogueira MA, Oliveira CPMS de, Alves VAF, Stefano JT, Rodrigues LS dos R, Torrinhas RS, Cogliati B, Barbeiro HV, Carrilho FJ, Waitzberg DL. Omega-3 polyunsaturated fatty acids in treating non-alcoholic steatohepatitis: a randomized, double-blind, placebo-controlled trial [Internet]. Clinical Nutrition. 2016 ; 35( 3): 578-586.[citado 2024 jun. 30 ] Available from: https://doi.org/10.1016/j.clnu.2015.05.001
Vancouver
Nogueira MA, Oliveira CPMS de, Alves VAF, Stefano JT, Rodrigues LS dos R, Torrinhas RS, Cogliati B, Barbeiro HV, Carrilho FJ, Waitzberg DL. Omega-3 polyunsaturated fatty acids in treating non-alcoholic steatohepatitis: a randomized, double-blind, placebo-controlled trial [Internet]. Clinical Nutrition. 2016 ; 35( 3): 578-586.[citado 2024 jun. 30 ] Available from: https://doi.org/10.1016/j.clnu.2015.05.001
Artigo de periodico
The complement component C5 promotes liver steatosis and inflammation in murine non-alcoholic liver disease model (2016)
Bavia, Lorena; Cogliati, Bruno; Dettoni, Juliano Bertollo; Alves, Venâncio Avancini Ferreira; Isaac, Lourdes
Source: Immunology Letters. Unidades: FMVZ, FM, ICB
Subjects: HEPATOPATIAS, INFLAMAÇÃO, PROTEÍNAS DA MEMBRANA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BAVIA, Lorena et al. The complement component C5 promotes liver steatosis and inflammation in murine non-alcoholic liver disease model. Immunology Letters, v. 177, p. 53-61, 2016Tradução . . Disponível em: https://doi.org/10.1016/j.imlet.2016.07.014. Acesso em: 30 jun. 2024.
APA
Bavia, L., Cogliati, B., Dettoni, J. B., Alves, V. A. F., & Isaac, L. (2016). The complement component C5 promotes liver steatosis and inflammation in murine non-alcoholic liver disease model. Immunology Letters, 177, 53-61. doi:10.1016/j.imlet.2016.07.014
NLM
Bavia L, Cogliati B, Dettoni JB, Alves VAF, Isaac L. The complement component C5 promotes liver steatosis and inflammation in murine non-alcoholic liver disease model [Internet]. Immunology Letters. 2016 ; 177 53-61.[citado 2024 jun. 30 ] Available from: https://doi.org/10.1016/j.imlet.2016.07.014
Vancouver
Bavia L, Cogliati B, Dettoni JB, Alves VAF, Isaac L. The complement component C5 promotes liver steatosis and inflammation in murine non-alcoholic liver disease model [Internet]. Immunology Letters. 2016 ; 177 53-61.[citado 2024 jun. 30 ] Available from: https://doi.org/10.1016/j.imlet.2016.07.014
Artigo de periodico
Strategies, models and biomarkers in experimental non-alcoholic fatty liver disease research (2015)
Willebrords, Joost; Pereira, Isabel Veloso Alves; Maes, Michaël; Yanguas, Sara Crespo; Colle, Isabelle; Bossche, Bert Van Den; Silva, Tereza Cristina da; Oliveira, Cláudia Pinto Marques Souza de; Andraus, Wellington; Alves, Venâncio Avancini Ferreira; Cogliati, Bruno; Vinken, Mathieu
Source: Progress in Lipid Research. Unidades: FM, FMVZ
Subjects: FÍGADO GORDUROSO, BIOMARCADORES, MODELOS ANIMAIS DE DOENÇAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WILLEBRORDS, Joost et al. Strategies, models and biomarkers in experimental non-alcoholic fatty liver disease research. Progress in Lipid Research, v. 59, p. 106-125, 2015Tradução . . Disponível em: https://doi.org/10.1016/j.plipres.2015.05.002. Acesso em: 30 jun. 2024.
APA
Willebrords, J., Pereira, I. V. A., Maes, M., Yanguas, S. C., Colle, I., Bossche, B. V. D., et al. (2015). Strategies, models and biomarkers in experimental non-alcoholic fatty liver disease research. Progress in Lipid Research, 59, 106-125. doi:10.1016/j.plipres.2015.05.002
NLM
Willebrords J, Pereira IVA, Maes M, Yanguas SC, Colle I, Bossche BVD, Silva TC da, Oliveira CPMS de, Andraus W, Alves VAF, Cogliati B, Vinken M. Strategies, models and biomarkers in experimental non-alcoholic fatty liver disease research [Internet]. Progress in Lipid Research. 2015 ; 59 106-125.[citado 2024 jun. 30 ] Available from: https://doi.org/10.1016/j.plipres.2015.05.002
Vancouver
Willebrords J, Pereira IVA, Maes M, Yanguas SC, Colle I, Bossche BVD, Silva TC da, Oliveira CPMS de, Andraus W, Alves VAF, Cogliati B, Vinken M. Strategies, models and biomarkers in experimental non-alcoholic fatty liver disease research [Internet]. Progress in Lipid Research. 2015 ; 59 106-125.[citado 2024 jun. 30 ] Available from: https://doi.org/10.1016/j.plipres.2015.05.002

USP Schools

ReP

Filtros

Departament

Authors

USP affiliated authors

Date published

Subjects

Source title

Countries/Territories

Indexado em

Non normalized affiliation